Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1

This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of gastrointestinal adverse events.

Study Information

JAMA. 2023 Nov 14;330(18):1795-1797. doi: 10.1001/jama.2023.19574. PMID: 37796527; PMCID: PMC10557026. 

Full Study

https://pubmed.ncbi.nlm.nih.gov/37796527/

Recent news

Gut microbiota's role in the enhancement of type 2 diabetes treatment by a tradi
Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic contro
Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver
Design, synthesis and biological evaluation of cinnamic acid derivatives with sy
Cinnamaldehyde attenuates streptozocin-induced diabetic osteoporosis in a rat mo
Recent news
Gut microbiota's role in the enhancement of type 2 diabetes treatment by a tradi
Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic contro
Antioxidative effects of Cinnamomi cassiae and Rhodiola rosea extracts in liver
Design, synthesis and biological evaluation of cinnamic acid derivatives with sy
Cinnamaldehyde attenuates streptozocin-induced diabetic osteoporosis in a rat mo
Next article Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance

Latest Articles

Is Your Immune System Ready for Winter? Antioxidants
Dr. Linda J. Dobberstein, DC, Board Certified in Clinical Nutrition

Is Your Immune System Ready for Winter?

View details
Does Your Protein Supplement Contain Lead? Protein
Dr. Linda J. Dobberstein, DC, Board Certified in Clinical Nutrition

Does Your Protein Supplement Contain Lead?

View details
Next-Generation Gut Support: Introducing the New Super Dophilus Allergies
Dr. Linda J. Dobberstein, DC, Board Certified in Clinical Nutrition

Next-Generation Gut Support: Introducing the New Super Dophilus

View details